What is USANA Health Sciences's hiya — cost of sales?

USANA Health Sciences (USNA) reported hiya — cost of sales of $9.98M in Q1 2026.

How has USANA Health Sciences's hiya — cost of sales changed year-over-year?

USANA Health Sciences's hiya — cost of sales decreased by 29.2% year-over-year, from $14.11M to $9.98M.

What does hiya — cost of sales mean?

Includes the direct costs attributable to the production and distribution of goods or services sold within the Hiya segment. This encompasses raw materials, direct labor, and manufacturing overheads directly associated with the segment's revenue generation. Monitoring this metric is critical for assessing the segment's gross margin and production efficiency.

USANA Health Sciences USNA Hiya — Cost of Sales

Other segment segments

Core Nutritional

$36.75M—

Rise

$12.7M—

Similar metrics at other companies

CROXHEYDUDE Brand — Cost of Sales

$86.35M-8.0%

TLSProduct — Cost of Sales

$4.53M+215%

BCPCHuman Nutrition and Health — Cost of Sales

$105.77M+6.4%

GICReportable Segment — Cost of Sales

$228.5M+9.4%

TWIConsumer — Cost of Sales

$117.87M-2.1%

SOLVHealth Information Systems — Cost of Sales

$80M-9.1%

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's hiya — cost of sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's hiya — cost of sales?: USANA Health Sciences (USNA) reported hiya — cost of sales of $9.98M in Q1 2026.
How has USANA Health Sciences's hiya — cost of sales changed year-over-year?: USANA Health Sciences's hiya — cost of sales decreased by 29.2% year-over-year, from $14.11M to $9.98M.
What does hiya — cost of sales mean?: Includes the direct costs attributable to the production and distribution of goods or services sold within the Hiya segment. This encompasses raw materials, direct labor, and manufacturing overheads directly associated with the segment's revenue generation. Monitoring this metric is critical for assessing the segment's gross margin and production efficiency.